Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
July 24 2024 - 4:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced it will report financial results for the
second quarter 2024 after market close on Wednesday, August 7,
2024. Company management will webcast a corresponding conference
call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern
Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.guardanthealth.com. The
webcast will be archived and available for replay after the
event.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on guarding wellness and giving every person more time free from
cancer. Founded in 2012, Guardant is transforming patient care and
accelerating new cancer therapies by providing critical insights
into what drives disease through its advanced blood and tissue
tests, real-world data and AI analytics. Guardant tests help
improve outcomes across all stages of care, including screening to
find cancer early, monitoring for recurrence in early-stage cancer,
and treatment selection for patients with advanced cancer. For more
information, visit guardanthealth.com and follow the company on
LinkedIn, X (Twitter) and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240724630393/en/
Investor Contact: Zarak Khurshid
investors@guardanthealth.com
Media Contact: Melissa Marasco press@guardanthealth.com
+1 650-647-3711
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Guardant Health (NASDAQ:GH)
Historical Stock Chart
From Aug 2023 to Aug 2024